S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
66,000% upside on tiny biotech? (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Something is Coming for America's Top Stock (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
66,000% upside on tiny biotech? (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
66,000% upside on tiny biotech? (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Something is Coming for America's Top Stock (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
66,000% upside on tiny biotech? (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
66,000% upside on tiny biotech? (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Something is Coming for America's Top Stock (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
66,000% upside on tiny biotech? (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
66,000% upside on tiny biotech? (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Something is Coming for America's Top Stock (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
66,000% upside on tiny biotech? (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
OTCMKTS:DNPUF

Sumitomo Pharma (DNPUF) Stock Forecast, Price & News

$3.64
0.00 (0.00%)
(As of 10/3/2023 ET)
Compare
Today's Range
$3.64
$3.64
50-Day Range
$3.59
$4.37
52-Week Range
$3.59
$7.60
Volume
N/A
Average Volume
1,467 shs
Market Capitalization
N/A
P/E Ratio
0.06
Dividend Yield
395.36%
Price Target
N/A

Sumitomo Pharma MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
-0.50mentions of Sumitomo Pharma in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.83 out of 5 stars


DNPUF stock logo

About Sumitomo Pharma (OTCMKTS:DNPUF) Stock

Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides products for atypical antipsychotic, cultured thymus tissue for pediatric congenital athymia, antiepileptic, and carbapenem antibiotic; and Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, as well as seasonings, such as soups or bouillons; and chemical product materials, which include pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, such as dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. Sumitomo Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application; Kyoto University; and Aikomi Co., Ltd., as well as a joint development agreement with SanBio Company Limited; and collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company also has a strategic alliance with Roivant Sciences Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.

DNPUF Price History

DNPUF Stock News Headlines

Elon Did It Again: This Could be Bigger than Tesla
Love him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.
Sumitomo Metal Industries
3 Pharma Stocks That Will Boom Thanks to AI
Elon Did It Again: This Could be Bigger than Tesla
Love him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.
Sumitomo Pharma Co., Ltd. (DNPUF)
Revisiting Myovant...
Sumitomo Pharma Co Ltd
Sumitomo Dainippon Pharma Co. Ltd (DNPUF)
See More Headlines
Receive DNPUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sumitomo Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:DNPUF
CIK
N/A
Fax
N/A
Employees
6,250
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Hiroshi Nomura (Age 66)
    CEO, Pres & Representative Director
    Comp: $688.52k
  • Mr. Toru Kimura Ph.D. (Age 63)
    Sr. Mngg Exec. Off. of Glo. Crprate Stgy, F&A, Regen & Cell Med. Off., Kobe Ctr, Mfg. Plt and Dir.
  • Mr. Hiroyuki Baba (Age 64)
    Mngg Exec. Officer of Global Data Design, Lgl Affairs. IP, IT Mgt, & Frontier Bus. Off. & Director
  • Mr. Naoki Noguchi
    Exec. Officer of Corp. Governance & Communications, VP and Head of Corp. Communications
  • Mr. Takuya Taguchi
    M.E.O. of Sales & Marketing Div., SVP, Hd of Sales & Marketing Div. and Dep. Hd of Japan Bus. Unit
  • Ms. Atsuko Higuchi
    Managing Exec. Officer of External Affairs, Corp. Secretariat & HR
  • Mr. Yoshiharu Ikeda Ph.D. (Age 65)
    Managing Exec. Officer of Drug Research Division, Head of Japan Bus. Unit & Director
  • Mr. Koichi Kozuki
    E.O. of R. Aff., Med. Sci., C.R.C. & Q.A., Sr. VP, Hd of C.R.C. & Q.A. Div and Dp. Hd of Japan Bus.
  • Dr. Shigeyuki Nishinaka Ph.D. (Age 59)
    Managing Exec. Officer of Bus. Devel. & Management and Director
  • Mr. Isao Shimizu
    Exec. Officer, Sr. VP, Head of Drug Research Division & Sr. Exec. Research Director













DNPUF Stock - Frequently Asked Questions

Should I buy or sell Sumitomo Pharma stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sumitomo Pharma in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DNPUF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DNPUF, but not buy additional shares or sell existing shares.
View DNPUF analyst ratings
or view top-rated stocks.

How have DNPUF shares performed in 2023?

Sumitomo Pharma's stock was trading at $7.40 at the start of the year. Since then, DNPUF stock has decreased by 50.9% and is now trading at $3.6350.
View the best growth stocks for 2023 here
.

Are investors shorting Sumitomo Pharma?

Sumitomo Pharma saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 5,538,000 shares, an increase of 14.4% from the August 31st total of 4,842,500 shares. Based on an average daily volume of 5,200 shares, the short-interest ratio is presently 1,065.0 days.
View Sumitomo Pharma's Short Interest
.

Is Sumitomo Pharma a good dividend stock?

Sumitomo Pharma (OTCMKTS:DNPUF) pays an annual dividend of $14.37 per share and currently has a dividend yield of 1.27%. The dividend payout ratio is 24.70%. This payout ratio is at a healthy, sustainable level, below 75%.

What is Sumitomo Pharma's stock symbol?

Sumitomo Pharma trades on the OTCMKTS under the ticker symbol "DNPUF."

How do I buy shares of Sumitomo Pharma?

Shares of DNPUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sumitomo Pharma's stock price today?

One share of DNPUF stock can currently be purchased for approximately $3.64.

How many employees does Sumitomo Pharma have?

The company employs 6,250 workers across the globe.

How can I contact Sumitomo Pharma?

Sumitomo Pharma's mailing address is 2-6-8 Dosho-machi, Osaka, 541-0045. The official website for the company is www.ds-pharma.com. The company can be reached via phone at 81 6 6203 5321.

This page (OTCMKTS:DNPUF) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -